On November 3, 2025, Longevity Health Holdings, Inc. amended their merger agreement to acquire True Health and its related licenses, including a stock valuation based on $59 million and earnout shares worth $20 million. This event is significant as it enhances their operational capabilities and regulatory approvals from the FDA.